# A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration

> **NCT00333476** · PHASE2 · TERMINATED · sponsor: **Genaera Corporation** · enrollment: 140 (—)

## Conditions studied

- Macular Degeneration

## Interventions

- **DRUG:** MSI-1256F (Squalamine Lactate)

## Key facts

- **NCT ID:** NCT00333476
- **Lead sponsor:** Genaera Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 140 (—)
- **Last updated:** 2007-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00333476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00333476, "A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00333476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*